Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Urologic Diseases
>>
Amgen
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Vectibix
(panitumumab) / Amgen
Parsabiv
(etelcalcetide) / Amgen
trebananib
(AMG 386) / Amgen
CCX140
/ Amgen, CSL Behring
Stivarga
(regorafenib) / Bayer
rilotumumab
(AMG 102) / Amgen
